Study: Delirium High After Therapeutic Hypothermia for Cardiac Arrest
The researchers reviewed the medical charts of patients treated in the cardiovascular intensive care unit (ICU) at Vanderbilt University Medical Center, Nashville, Tennessee, USA. Of 107 patients who survived and awoke from coma all experienced at least one day of delirium between rewarming and being discharged from the ICU. The study also investigated risk factors for delirium.
Jeremy Pollock, MD, fellow in the division of cardiovascular medicine at the University of Maryland Medical Center, Baltimore, said that this high prevalence shows the need for a better understanding of the relationship between delirium and long-term outcomes.
See Also: Earplugs Are Effective in Reducing Risk of Delirium
The researchers found that in the patient group studied age and longer times from initiation of CPR to return of spontaneous circulation were associated with increased duration of delirium. After resuscitation risk factors were doses of propofol, with higher total doses of propofol while comatose being protective against delirium. They suggest that the degree of injury induced by cardiac arrest, the swings in metabolism from therapeutic hypothermia and the psychoactive medication doses were likely contributory factors to delirium.
The researchers recommend further research to understand the relationship between sedative and paralytic choice during therapeutic hypothermia and prevalence and duration of delirium, as well as the relationship between delirium, sedation and long-term outcomes in patients treated with therapeutic hypothermia after cardiac arrest.
Published on : Mon, 11 Jul 2016
Print as PDF
Get an complete overview of your POCT setup - from one dashboard Your point-of-care-testing setup probably involves many different types of devices from various manufacturers. Radiometer's AQURE point-of-care management system can give you an overview...
NovaPort cannulas: The safe access to the vascular system. NovaPort® twin double lumen cannulas are specifically developed for veno-venous vascular access. NovaPort one single lumen cannulas are specifically developed for the percutaneous connection (KU)...
The technical and clinical reference standard for all B·R·A·H·M·S PCT assays. All clinical cut-offs and algorithms were developed based on B·R·A·H·M·S PCT sensitive KRYPTOR. Homogeneous immunoassay for the quantitative d
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....